Table 2.
Univariate and multivariate analysis of clinicopathological factors in patients with pancreatic cancer
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | |||
| Sex | 0.71 (0.449-1.133) | 0.152 | ||||
| Age | 1.61 (0.928-2.805) | 0.898 | ||||
| USP5 | 2.28 (1.392-3.734) | 0.001 | 1.72 (1.014-2.90) | 0.044 | ||
| Tumor site | 0.69 (0.440-1.089) | 0.112 | ||||
| Differentiation | 0.29 (0.148-0.561) | <0.001 | 2.44 (1.200-4.940) | 0.014 | ||
| T stage | 1.12 (0.708-1.773) | 0.627 | ||||
| N stage | 1.11 (0.554-2.229) | 0.765 | ||||
| M stage | 2.42 (0.750-7.799) | 0.139 | ||||
| pTNM | 0.94 (0.580-1.509) | 0.784 | ||||
| CEA | 060 (0.373-0.952) | 0.030 | 0.91 (0.543-1.534) | 0.729 | ||
| CA199 | 0.43 (0.248-0.753) | 0.003 | 0.58 (0.315-1.075) | 0.084 | ||